D-0002-2021 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0002-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Sep 23, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product. The recall status is terminated (terminated Nov 3, 2021). Affected quantity: 747 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 7, 2020
Initiation Date
Sep 23, 2020
Termination Date
Nov 3, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
747 bottles

Product description

RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL 16 oz. For Oral Use Only Rx Only Manufactured by: Sun Pharmaceuticals Industries Limited Mohali, India Distributed by: Sun Pharmaceuticals Industries, Inc. Cranbury, NJ 08512 NDC 10631-019-17

Reason for recall

CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.

Distribution pattern

Nationwide

Code information

Lot #: AB06381; Exp 10/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0002-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0002-2021. Report a data issue: hello@regdatalab.com.